Download Duke Presentations at the AHA - Duke Clinical Research Institute

Saturday, November 3
9:00–11:36 am
Petree Hall C
L. Kristin Newby, moderator
10:45–10:57 am
Petree Hall C
Early Career: Opening General Session
Clinicians Working with Quantitative Scientists
Early Career: Opening General Session
Robert M. Califf
11:30 am –1:00 pm
JW Marriott at
LA LIVE,
Gold Ballroom
Best Original Resuscitation Science Poster Session and Luncheon
The Method Matters: Community Consultation Methods Influence Attitudes and Understanding of
Proposed Trial Using Exception from Informed Consent for Research in Emergency Settings
Victoria Mah, Neal W. Dickert, Michelle H. Biros, Deneil Harney, Robert E. Silbergleit, Jeremy Sugarman,
Kevin P. Weinfurt, David W. Wright, Rebecca D. Pentz
Ex Vivo Assessment of Normothermic Myocardial Ischemia/Reperfusion Injury in Winter-Active Arctic
Ground Squirrels
Matthias L. Riess, Brian M. Barnes, Mihai V. Podgoreanu
Survival from Out-of-Hospital Cardiac Arrest Is Lowest at Night: Findings from the Cardiac Arrest
Registry to Enhance Survival (CARES)
Akshay Bagai**, Bryan McNally, Brent Myers, Sunghee Kim, Sean van Diepan, J. Lee Garvey,
Emil L. Fosbol, Lisa Monk, Benjamin S. Abella, Christopher B. Granger, James G. Jollis
Cardiac Arrest and Cardiopulmonary Resuscitation Knowledge at an Academic Research Organization
in Durham, North Carolina
Monique L. Anderson**, James G. Jollis, Eric D. Peterson, Renato D. Lopes, Rosalia G. Blanco,
Elizabeth Fraulo, Joshua Pathman, Angel Moore, Leatrice Short, Christopher B. Granger
12:00–1:00 pm
Hall A-6
L. Kristin Newby, mentor
1:00–1:10 pm
Hall A-5
W. Schuyler Jones, introduction
1:00–2:45 pm
Hall A-4
Tracy Y. Wang, Manesh R. Patel, moderators
1:00–5:00 pm
Hall A-5
W. Schuyler Jones, moderator
1:05–1:10 pm
Hall A-4
Early Career: Training and Funding—How to Get Started as an Early Career Investigator
Training to Become a Successful Cardiovascular Researcher (from Trainee to Independent Investigator)
Early Career: Lunch with the Mentor (Bring Your Own Lunch)
Early Career: Interventional Cardiology Fellows Program
Early Career: Training and Funding—How to Get Started as an Early Career Investigator
Early Career: Interventional Cardiology Fellows Program
Tracy Y. Wang, panelist
1:10–1:15 pm
Hall A-4
Early Career: Training and Funding—How to Get Started as an Early Career Investigator
Training to Become a Successful Cardiovascular Researcher (from Trainee to Independent Investigator)
Manesh R. Patel, panelist
1:30–1:45 pm
Hall A-3
Early Career: Pediatric Cardiology—Street Smart Career Guidance (planned by the Council on
Cardiovascular Disease in the Young)
Making the Transition from Fellow to Staff, Including Negotiating a Great First Job
Sara K. Pasquali
•
Duke speakers and authors in bold. **DCRI fellows or incoming fellows
Duke at AHA 2012
Duke at AHA 2012
Saturday, November 3
1:55–2:25 pm
Hall A-11
Early Career: How to Succeed and Thrive as a Cardiovascular Physician (planned by the Council on
Clinical Cardiology)
How to Get Involved in Clinical Research: Types of Research
Adrian F. Hernandez, panelist
3:00–3:30 pm
Hall A-7
Early Career: Starting a Successful Career in Quality of Care and Outcomes Research (planned by the
QCOR Council)
Transforming Healthcare Delivery Through Cardiovascular Registries
Eric D. Peterson
3:00–4:15 pm
Hall A-12
Richard C. Becker, moderator
3:00–4:30 pm
Hall A-4
Early Career: Research Career Pathways within Epidemiology, Nutrition, Physical Activity and Metabolism
(planned by the EPI/NPAM Councils)
Abstract Oral Session: Samuel A. Levine Young Clinical Investigator Award Finalists
Mahesh J. Patel, moderator
3:00–5:00 pm
Hall A-7
Early Career: Starting a Successful Career in Quality of Care and Outcomes Research (planned by the
QCOR Council)
Tracy Y. Wang, moderator
3:20–3:55 pm
Hall A-11
Early Career: How to Succeed and Thrive as a Cardiovascular Physician (planned by the Council on
Clinical Cardiology)
Time Management: How to Balance Patient Care, Research, Teaching, Administrative Roles, and Family Life
Karen P. Alexander, panelist
8:30–9:00 pm
Westin Bonaventure
Hotel & Suites,
San Diego Room
AHA Cardiovascular Evening Symposium
Treatment of Residual Arrhythmia after Ablation
Patrick Hranitzky
Sunday, November 4
9:06–9:28 am
Room 502b
Sunday Morning Program
Anticoagulants and Antiplatelet Therapy in ACS Patients with Diabetes: Do They Benefit from More
Aggressive Treatment?
Richard C. Becker
9:45–9:55 am
Theater (Room 411)
Sunday Morning Program
Diuretic Strategies in Patients with Acute Decompensated Heart Failure
G. Michael Felker
9:45–10:10 am
Room 303
Sunday Morning Program
Magnetic Resonance Imaging
Raymond J. Kim
9:30–11:00 am
Kentia Hall
Abstract Poster Session
Core 7, Poster 7002
The Actin-Binding Protein Drebrin Reduces TRP Channel Activity and Neointimal Hyperplasia
Jonathan A. Stiber, Lisheng Zhang, Igor Nepliouev, Zhu-Shan Zhang, Jiao-Hui Wu,
Paul B. Rosenberg, Neil J. Freedman
Core 6, Poster 6003
Mitral Regurgitation Severity Is Associated with Renal Function: Post-Hoc Analysis of the EVEREST II Trials of
Transcatheter Mitral Valve Repair
Andrew Wang, Chithra Sangli, Donald Glower, Ted Feldman
Duke at AHA 2012
Duke at AHA 2012
Sunday, November 4
Abstract Poster Session (cont.)
Core 2, Poster 2085
Race/Ethnic Differences in Mortality among Patients Hospitalized with Intracerebral Hemorrhage
Ying Xian, Robert G. Holloway, Eric E. Smith, Lee H. Schwamm, Mathew J. Reeves, Margueritte Cox,
DaiWai M. Olson, Adrian F. Hernandez, Barbara Lytle, Gregg C. Fonarow, Eric D. Peterson
11:30 am –12:40 pm
Hall A-10
11:30 am –1:00 pm
JW Marriott at
LA LIVE,
Gold Ballroom
International Forum: Canada
Augustus O. Grant, moderator
Best Original Resuscitation Science Poster Session and Luncheon
CT Imaging of Pediatric Heart Deformation During Chest Compressions
George F Glass III, Richard Kent, Matthew Maltese, Dale Bass, Mark Sochor
Simulation of Cardiac Arrhythmias in Hospitalized Patients to Measure and Improve Response Time
Melanie C. Wright, Kyle W. Dorsey, Robert DeLong, Ronda Decker, Anita Patterson,
Kathryn McBroom, Christopher B. Granger
12:20–12:35 pm
Hall A-1
L. Kristin Newby, panelist
12:20–12:35 pm
Hall A-12
Christopher B. Granger, panelist
12:20–12:35 pm
Hall A-8
Manesh R. Patel, panelist
3:00–4:30 pm
Kentia Hall
International Forum: United Kingdom
International Forum: Argentina
International Forum: Germany
Abstract Poster Session
Core 2, Poster 2083
High Blood Pressure Increases Risk of Death among Human Immunodeficiency Virus Seropositive
Individuals in Kenya
Gerald S. Bloomfield, Joseph W. Hogan, Alfred Keter, Thomas L. Holland, James Osanya, Edwin Sang,
Sylvester Kimaiyo, Eric J. Velazquez
Core 3, Poster 3016
Pharmacometabolomics Reveals a Novel Signature for Predicting Beta Blocker Associated Impaired
Fasting Glucose
Rhonda M Cooper-DeHoff, Wei Hou, Rebecca Baillie, Amber L. Beitelshees, Yan Gong, Arlene B. Chapman,
John G. Gums, Stephen T. Turner, Stephen H. Boyle, Hongjie Zhu, Willian R. Wikoff, Oliver Fiehn, Reginald F.
Frye, Rima Daddurah-Daouk, Julie A. Johnson
Core 3, Poster 3038
Evaluation of Syncope and Its Electrophysiologic Associations in Children and Adolescents: A Pediatric
Referral Center Experience
Chandra Srinivasan, Christoph P. Hornik, Angela Lloyd, Christine Meliones, Michael P. Carboni, William Darden,
Ronald J. Kanter
Core 7, Poster 7096
Patient and Neighborhood Factors Associated with Presentation Delay in ST-Elevation Myocardial
Infarction: Insights from the NCDR®
Amy Leigh Miller, DaJuanicia Holmes, Matthew T. Roe, Michael C. Kontos, Deborah B. Diercks,
Ezra Amsterdam, Deepak L. Bhatt, Tracy Y. Wang
Duke at AHA 2012
Duke at AHA 2012
Sunday, November 4
Abstract Poster Session (cont.)
Core 2, Poster 2047
Clinical Characteristics and Outcomes of Patients with Insulin Receiving and Non-Insulin Receiving Diabetes
Mellitus Presenting with Myocardial Infarction: An Analysis from the NCDR®
Talla A. Rousan, Anita Y. Chen, Reji M. Pappy, Matthew T. Roe, Jorge F. Saucedo
Core 7, Poster 7099
Bypassing the Emergency Department Is Associated with Faster Reperfusion in Patients with Pre-Hospital
ST-Segment Elevation: A Report from the AHA Mission: Lifeline Program
Akshay Bagai**, James G. Jollis, Harold L. Dauerman, S. Andrew Peng , Eric R. Bates, William J. French,
Christopher B. Granger, Matthew T. Roe
Core 7, Poster 7066
Anatomic and Physiologic Determinants of the Area-at-Risk Differentiate in Range of Infarct Size among
Patients Undergoing Primary Percutaneous Coronary Intervention
Ralf E. Harskamp**, Joost D. Haeck, Ecaterina Cristea, Jan G. Tijssen, Karel T. Koch, Mitchell W. Krucoff,
Robbert J. de Winter
Core 6, Poster 6041
Influence of Myocardial Viability on the Outcome of Patients with Coronary Artery Disease and Left
Ventricular Dysfunction Undergoing Coronary Bypass Surgery With and Without Surgical Ventricular
Reconstruction: Results of the Surgical Treatment for Ischemic Heart Failure (STICH) Trial
Thomas A. Holly, Robert O. Bonow, J. Malcolm O. Arnold, Jae K. Oh, Padmini Varadarajan,
Gerald M. Pohost, Haissam Haddad, Robert H. Jones, Federico M. Asch, Marcin Malinowski,
Rodrigo Barretto, Renato A. K. Kalil, Daniel S. Berman, Kerry L. Lee, Julio A. Panza
Core 4, Poster 4040
Comparing Symptoms and Quality of Life in Women and Men with Atrial Fibrillation: Results from the
ORBIT-AF Registry
Jonathan P. Piccini, DaJuanicia N. Holmes, Laine Thomas, Larry A. Allen, Gregg C. Fonarow,
Bernard J. Gersh, Peter R. Kowey, James A. Reiffel, Gerald V. Naccarelli, Paul Chang, Paul S. Chan,
John A. Spertus, Eric D. Peterson
Core 2, Poster 2072
Lower Education Level Is Associated with Non-Adherence to Dual Antiplatelet Therapy after PCI: 6-Month
Results from PARIS
Ziad Sergie, Samantha Sartori, Giora Weisz, Bernhard Witzenbichler, Timothy D. Henry, Annapoorna Kini,
Thomas Stuckey, David J. Cohen, Peter B. Berger, Alaide Chieffo, Fayaz Shawl, Philippe Gabriel Steg,
David J. Moliterno, James B. Hermiller, David Antoniucci, Ron Waksman, Mitchell W. Krucoff,
Pushpam Bharathi, Sharon Choi, Patrick Looser, Usman Baber, Roxana Mehran
Core 2, Poster 2099
Access to Care: Geographical Variations in the Diagnosis and Treatment of Aortic Stenosis in North Carolina
John P. Vavalle, Harry Phillips III, Sara Holleran, Andrew Wang, Christoper M. O'Connor,
Peter K. Smith, G. Chad Hughes, J. Kevin Harrison, Manesh R. Patel
Core 3, Poster 3002
Peripheral Blood Gene Expression Reflects Differences Between Coronary Artery Calcification and Stenosis
as Assessed by Coronary Artery Calcium Scanning and CT Angiography
Szilard Voros, Matthew J. Budoff, William Kraus, Gregory Thomas, Michael Elashoff, James Wingrove,
Steven Rosenberg
Duke at AHA 2012
Duke at AHA 2012
Sunday, November 4
4:14–4:24 pm
Hall G
Late-Breaking Clinical Trials: Practice Implications for CAD and VTE
First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial—The TRILOGY ACS
Platelet Function Sub-study
Paul A. Gurbel, presenter; David Erlinge, E. Magnus Ohman, Benjamin Neely, Megan Neely,
Joseph A. Jakubowski, Shaun G. Goodman, Kurt Huber, Mark Y. Chan, Jan H. Cornel, Eileen Brown,
Chunmei Zhou, Harvey D. White, Keith A. Fox, Dorairaj Prabhakaran, Paul W. Armstrong, Udaya S. Tantry,
Matthew T. Roe
4:15–4:30 pm
Room 511
Abstract Oral Session
Aspirin Exposure Reveals Novel Genes Associated with Platelet Function and Cardiovascular Events
Deepak Voora, Derek Cyr, Joseph Lucas, Jen-Tsan Chi, Jennifer Dungan, Timothy McCaffrey,
Richard Katz, L. Kristin Newby, William Kraus, Richard C. Becker, Thomas Ortel, Geoffrey Ginsburg
4:30–4:45 pm
Room 515b
Abstract Oral Session
Intervention for Re-Coarctation in the Single Ventricle Reconstruction Trial: Incidence, Risk, and Outcomes
Kevin D. Hill, John F. Rhodes, Ranjit Aiyagari, G. Hamilton Baker, Lisa Bergersen, Paul J. Chai,
Gregory A. Fleming, J. Curt Fudge, Matthew J. Gillespie, Robert G. Gray, Russel Hirsch, Kyong-Jin Lee,
Jennifer S. Li, Richard G. Ohye, Matthew E. Oster, Sara K. Pasquali, Andrew M. Pelech, Wolfgang A.K.
Radtke, Cheryl M. Takao, Julie A. Vincent, Christoph P. Hornik
4:36–4:46 pm
Hall G
Late-Breaking Clinical Trials: Practice Implications for CAD and VTE
Results of the Trial to Assess Chelation Therapy
Gervasio A Lamas, presenter; Robin Boineau, Christine Goertz, Dan B. Mark, Theodore C. Rozema,
Richard L. Nahin, Yves Rosenberg, Mario Stylianou, Jeanne Drisko, Kerry L. Lee
5:30–5:45 pm
Room 515b
What's Going on in Pediatric Cardiovascular Pharmacology
Recent and Ongoing Pediatric Cardiovascular Drug Trials
Jennifer S. Li
5:30–5:45 pm
Room 404
Living Well with Atrial Fibrillation: Helping Patients Manage Their Disease
Living with Atrial Fibrillation: Lessons from Patients
Kathryn Wood
5:52–6:02 pm
Hall G
Late-Breaking Clinical Trials: Health Economics and Quality of Life in Contemporary Trials
Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site
Cardiac Surgery
E.L. Eisenstein, presenter; Linda Davidson-Ray, Rex Edwards, Kevin J. Anstrom, Daniel B. Mark, Thomas R.
Aversano
6:00–6:15 pm
Room 406
Cardiac Signaling: Specificity and Function in Physiology and Disease
Regulation of Beta-Arrestin Signaling Complexes
Howard Rockman
6:00–6:15 pm
Room 410
Disease Management Programs: What's New?
Latin American Update
Renato D. Lopes
6:00–6:15 pm
Hall A-5
Optimizing Outcomes in Dire Situations: Anesthesia and Critical Care Advances
Managing Vascular Complications and Hemorrhage from Percutaneous Devices
Jeffrey H. Lawson
Duke at AHA 2012
Duke at AHA 2012
Sunday, November 4
6:02–6:12 pm
Hall G
Late-Breaking Clinical Trials: Health Economics and Quality of Life in Contemporary Trials
Quality of Life Outcomes in the Trial to Assess Chelation Therapy (TACT)
Daniel B. Mark, presenter; Kevin J. Anstrom, Robin Boineau, Christine Goertz, Theodore C. Rozema,
J. David Knight, Nancy E. Clapp-Channing, Diane M. Liu, Richard L. Nahin, Yves Rosenberg,
Jeanne Drisko, Kerry L. Lee, Gervasio A. Lamas
6:15–6:30 pm
Room 408a
Bench-to-Bedside Translation of Cardiac Progenitor Cell Therapy
Cytokines' Effects: What, When, and How
Victor J. Dzau
6:30–6:45 pm
Room 410
Disease Management Programs: What's New?
The Business Case for Disease Management Programs
Christopher M. O’Connor
6:30–6:45 pm
Room 408b
Long-Term Management of VADs: Common Complications
Aortic Regurgitation
Chetan Patel
Monday, November 5
7:30–7:45 am
Hall A-4
Outcomes and Income: Quality Measure for Percutaneous Coronary Intervention
The Current Conundrum: The Challenge of Demonstrating High-Quality Practice
Manesh R. Patel
7:45–8:00 am
Room 502b
Ask the Experts
Interventional Trial Data Regarding Visceral and Ectopic Fat
Cris A. Slentz
7:45–8:00 am
Room 406
Tissue-Engineered Heart Repair
Tissue-Engineered Electrical Networks
Nenad Bursac
7:49–7:59 am
Petree Hall D
Clinical Science: Special Reports
Results of the Responses of Myocardial Ischemia to Escitalopram Treatment Trial
Wei Jiang
8:08–8:18 am
Petree Hall D
Clinical Science: Special Reports
Safety and Efficacy of Losmapimod in Non–ST-Segment Elevation Acute Myocardial Infarction:
Results of the SOLSTICE Phase 2 Randomized Trial
L. Kristin Newby
9:00–9:15 am
Room 511
Abstract Oral Session
Patterns of Discharge Aspirin Dosing in 213,344 U.S. Patients after Acute Myocardial Infarction:
Results from the NCDR®
Hurst M. Hall, Jonathan R. Enriquez, James A. de Lemos, Nihar Desai, S. Andrew Peng,
Karen P. Alexander, Matthew T. Roe, Darren K. McGuire, Stephen D. Wiviott, Sandeep R. Das
9:00–9:15 am
Room 503
Abstract Oral Session
Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose
Tolerance? Insights from the NAVIGATOR Study
Lan Shen**, Bimal Shah, Eric Reyes, Laine Thomas, Peter Diem, Lawrence Leiter, Bernard Charbonnel,
Viacheslav Mareev, Edward Horton, Steven Haffner, Vladimir Soska, Rury Holman, M. Angelyn Bethel,
Frank Schaper, Jie-Lena Sun, John McMurray, Robert M. Califf, Henry Krum
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
9:00–9:15 am
Room 515b
Abstract Oral Session
Predictors of Disease Progression in Pediatric Dilated Cardiomyopathy
Kimberly Molina, Lynn Sleeper, Seema Mital, Steven Colan, Peter Shrader, Piers Barker, Renee Margossian,
Girish Shirali, Karen Altmann, Charles Canter, Elizabeth Radojewski, Elif Tierney, Jack Rychik, Lloyd Tani
9:00–10:15 am
Hall G
Adrian F. Hernandez, moderator
9:00 am –12:00 pm
Room 408b
G. Michael Felker, moderator
9:15–9:30 am
Room 502a
Engineering Success for Heart Failure
Abstract Oral Session
Abstract Oral Session
Check It Change It: A Community-Based Hypertension Program
Kevin L. Thomas, Bimal R. Shah, Sharon Elliott-Bynum, Kristin D. Thomas, Katrina Damon,
Nancy Allen LaPointe, Sarah Calhoun, Laine Thomas , Khadijah Breathett, Robin Mathews,
Monique L. Anderson**, Robert M. Califf, Eric D. Peterson
9:30–11:00 am
Kentia Hall
Best of AHA Specialty Conferences: ATVB 2012
Poster ATVB14
B Lymphocytes Trigger MCP3-Dependent Mobilization of Monocytes and Promote Adverse Ventricular
Remodeling after Myocardial Infarction
Yasmine Zouggari, Hafid Ait-Oufella, Philippe Bonnin, José Vilar, Israel F Charo, Thomas F. Tedder, Alain
Tedgui, Jean-Sébastien Silvestre, Ziad Mallat
Best of AHA Specialty Conferences: ISC 2012
Poster ISC02
Efficacy and Safety of Rivaroxaban Compared with Warfarin Among Elderly Patients with Nonvalvular
Atrial Fibrillation in the ROCKET-AF Trial
Jonathan L. Halperin, Graeme J. Hankey, Daniel Wojdyla, Jonathan P. Piccini, Yuliya Lokhnygina, Manesh R.
Patel, Gunter Breithardt, Daniel E. Singer, Richard C. Becker, Werner Hacke, John F. Paolini, Christopher C.
Nessel, Kenneth W. Mahaffey, Robert M. Califf, Keith A. Fox
Best of AHA Specialty Conferences: QCOR 2012
Poster QCOR01
Outcomes Following Catheter Ablation of Atrial Fibrillation in Medicare Beneficiaries
Melissa A. Greiner, Jonathan P. Piccini, Moritz F. Sinner, Susan R. Heckbert, Emelia J. Benjamin,
Lesley H. Curtis
Best of AHA Specialty Conferences: QCOR 2012
Poster QCOR05
The Impact of an Emergency Medical Services Hospital Bypass Protocol on Reperfusion Time for Patients
with ST-Elevation Myocardial Infarction (STEMI)
Emil L. Fosbol, Christopher B. Granger, James G. Jollis, Lisa Monk, Li Lin, Barbara Lytle, Ying Xian, Lee Garvey,
Greg Mears, Claire M. Corbett, Eric D. Peterson, Seth Glickman
Best of AHA Specialty Conferences: QCOR 2012
Poster QCOR07
Incidence, Treatment, and Outcomes of Cardiogenic Shock in STEMI and NSTEMI: Results from the NCDR®
Monique L. Anderson**, Eric D. Peterson, E. Magnus Ohman, S. Andrew Peng, Matthew T. Roe
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
Best of AHA Specialty Conferences: QCOR 2012
Poster QCOR08
Hospital PCI Appropriateness and In-Hospital Procedural Outcomes: Insights from the NCDR®
Steven M. Bradley, Paul S. Chan, John A. Spertus, Kevin F. Kennedy, Pamela S. Douglas, Manesh R. Patel, H.
Vernon Anderson, Henry H. Ting, Brahmajee K. Nallamothu
Best of AHA Specialty Conferences: QCOR 2012
Poster QCOR15
Effectiveness of Bleeding Avoidance Strategies in Women and Men Following Percutaneous Coronary
Interventions: A Report from the NCDR®
Lauren E. Thompson, Frederick A. Masoudi, Sunghee Kim, Sunil V. Rao, Sumeet Subherwal,
Thomas T. Tsai, John Messenger, Stacie L. Daugherty
Best of AHA Specialty Conferences: QCOR 2012
Poster QCOR23
Increased Risk of Venous Thromboembolism Associated with Use of Non-Steroidal Anti-Inflammatory
Drugs among Patients with Prior Myocardial Infarction—A Nationwide Cohort Study
Anne-Marie Schjerning Olsen, Emil L. Fosbøl, Jesper Lindhardsen, Charlotte Andersson, Fredrik Folke,
Lars Køber, Christian Torp-Pedersen, Gunnar H. Gislason
Best of AHA Specialty Conferences: QCOR 2012
Poster QCOR26
Aldosterone Antagonists in Post-Acute Myocardial Infarction Use, Predictors, and Temporal Trends of a
Class I Recommendation
Andrew N. Rassi, Matthew A. Cavender, Gregg C. Fonarow, Christopher P. Cannon, Adrian F. Hernandez, Eric
D. Peterson, W. Frank Peacock, Warren K. Laskey, Xin Zhao, Lee H. Schwamm, Deepak L. Bhatt
Best of AHA Specialty Conferences: Best of HBPR 2012
Poster HBPR12
The Macula Densa PGE2 Activates Adult Renal CD44 + Mesenchymal Stromal Cell (MSC) Migration and
Differentiation to Renin Producing Cells via EP4 Receptor and Wnt Canonical Signaling
Yanqiang Yang, Jose Gomez, Marcela Herrera, Peter Repenning, Zhiping Zhang, Alan Payne,
Richard Pratt, Beverly Koller, Thomas Coffman, Maria Mirotsou, Victor J. Dzau
9:30–11:00 am
Kentia Hall
Abstract Poster Session
Core 5, Poster 5104
Cardiac Biomarker Elevation During Stem Cell Mobilisation, Apheresis, and Intramyocardial Delivery Is
Common but Does Not Impact Incidence of Long-Term MACE: An Analysis from ACT34-CMI
Thomas J. Povsic, Douglas W. Losordo, Kenneth Story, Candice E. Junge, Richard A. Schatz,
Robert A. Harrington, Timothy D. Henry
Core 4, Poster 4024
High Use of Concomitant Antiplatelet Therapy with Oral Anticoagulation in Patients with Atrial Fibrillation:
Results from the ORBIT-AF Registry
Benjamin A. Steinberg**, Sunghee Kim, Jack Ansell, Elaine Hylek, Kenneth W. Mahaffey,
Daniel E. Singer, Michael D. Ezekowitz, Gregg C. Fonarow, Alan S. Go, Peter Kowey, Laine Thomas,
Paul Chang, Jonathan P. Piccini, Eric D. Peterson
Core 2, Poster 2157
Unplanned 30-Day Readmission Risk among Patients with Acute Myocardial Infarction: A Report from
TRANSLATE-ACS
Connie N. Hess**, Tracy Y. Wang, Lisa Kaltenbach, Emily Honeycutt, John C. Messenger,
William T. Smith IV, Marjorie E. Zettler, Mark B. Effron, Timothy D. Henry, Eric D. Peterson,
Gregg C. Fonarow
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
Core 2, Poster 2160
Is 30-Day Readmission Preventable after Acute Myocardial Infarction? A New MI Patient-Specific Derivation
of the Intermountain Risk Score for 30-Day Readmission
Benjamin D. Horne, Jeffrey L. Anderson, Joseph B. Muhlestein, Kimberly D. Brunisholz, Heidi T. May,
Jason M. Lappé, Tami L. Bair, Donald L. Lappé
Core 2, Poster 2162
Use of Aldosterone Antagonists at Discharge after Myocardial Infarction: Results from the NCDR®
Krishnasree K. Rao, Jonathan R. Enriquez, James A. de Lemos, Karen P. Alexander, Anita Y. Chen,
Darren K. McGuire, Gregg C. Fonarow, Sandeep R. Das
Core 2, Poster 2163
Persistence of Secondary Prevention Medications after Acute Myocardial Infarction: Insights from the
TRANSLATE-ACS Study
Robin Mathews, Tracy Y. Wang, Emily Honeycutt, Timothy D. Henry, Michael Chang, Gregg C. Fonarow, Eric D.
Peterson
Core 2, Poster 2165
Persistence of Evidence-Based Medications after Non-ST Elevation Myocardial Infarction among Patients
with Medicare Part D Prescription Coverage
Emil L. Fosbol, Lisa Kaltenbach, Judith Stafford, Laine Thomas, Eric D. Peterson, Tracy Y. Wang
Core 6, Poster 6035
Acute Surgical Conversion during Transcatheter Aortic Valve Implantation (TAVI)—A Weighted MetaAnalysis of 9,251 Patients from 46 Studies
Holger Eggebrecht, Axel Schmermund, Thomas Voigtländer, Rajendra H. Mehta
Core 7, Poster 7123
Early ß-blocker and Renin Angiotensin Aldosterone Blocker Therapy in Patients with Acute Myocardial
Infarction and Ongoing Cardiogenic Shock Is Associated with Increased 30-Day Mortality: Insights from the
TRIUMPH Trial
Sean van Diepen**, Amanda Stebbins, Harmony R. Reynolds, Vladimir Dzavik, Withold Ruzyllo,
Judith S. Hochman, John H. Alexander
Core 7, Poster 7125
Impact of Diabetes on Clinical Findings, Management, and In-Hospital Outcomes in Non-ST Elevation and ST
Elevation Myocardial Infarction: An Analysis from the NCDR®
Reji M. Pappy, Anita Y. Chen, Talla A. Rousan, Matthew T. Roe, Jorge F. Saucedo
Core 7, Poster 7127
Worse Renal Function Is Associated with Markedly Worse Outcomes among STEMI Patients Undergoing
Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) Trial
John P. Vavalle, Sean van Diepen**, Renato D. Lopes, Robert Clare, Judith S. Hochman,
Douglas Weaver, Rajendra Mehta, Karen S. Pieper, Manesh R. Patel, Paul W. Armstrong,
Christopher B. Granger
Core 1, Poster 1006
A Practical Approach to Quality Assurance Implementation in Clinical Echocardiographic Laboratories
Melissa A. Daubert, Huiman X. Barnhart, Eric Yow, Dawn Rabineau, Pamela S. Douglas
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
Abstract Poster Session (cont.)
Core 6, Poster 6007
In-Hospital Switching of ADP Receptor Inhibitors in Myocardial Infarction Patients Treated with
Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study
Akshay Bagai**, Eric D. Peterson, Emily Honeycutt, Mark B. Effron, David J. Cohen,
Shaun G. Goodman, Kevin J. Anstrom, Anjan Gupta, John C. Messenger, Tracy Y. Wang
Core 6, Poster 6016
Bleeding Post PCI: Predictors of “ANY” Bleeds: Six-Month Results from the PARIS (Patterns of
Non-Adherence to Antiplatelet Regimens in Stented Patients) Registry
Jennifer Yu, Giora Weisz, Bernhard Witzenbichler, Timothy D. Henry, Annapoorna S. Kini,
Thomas Stuckey, David J. Cohen, Peter B. Berger, Antonio Colombo, Philippe Gabriel Steg,
David Moliterno, James Hermiller, Sylvia Xistris, Socrates Kakoulides, Catherine Cashy, Robert Kulina,
Mitchell W. Krucoff, Georgios Vlachojannis, Samantha Sartori, Roxana Mehran
10:00–10:15 am
Room 515b
Abstract Oral Session
Outcomes after Pediatric Heart Transplantation with Use of the Berlin Heart EXCOR Pediatric
Ventricular Assist Device
Pirooz Eghtesady, Christopher Almond, Christine Tjossem, Deidre Epstein, Michiaki Iamaura,
Turrentine Mark, James Tweddell, Robert Jaquiss, Charles E. Canter
10:45–11:00 am
Room 403a
Abstract Oral Session
Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the
ARISTOTLE Trial
Maria Cecilia Bahit, Renato D. Lopes, Stephan H. Hohnloser, Daniel Wojdyla, John H. Alexander,
Basil S. Lewis, Philip Aylward, Freek W.A. Verheugt, Matyas Keltai, Rafael Diaz, Puneet Mohan,
Christopher B. Granger, Lars Wallentin
10:45–11:00 am
Room 501a
Abstract Oral Session
Do Arrhythmia Symptoms and Outcomes Differ by Gender after Ablation?
Kathryn Wood, Mauro Lencioni, Hannah Partick, Kathleen Withers, David Cunningham, Michael Griffith
11:00–11:15 am
Room 511
Abstract Oral Session
The Systemic Inflammatory Response Syndrome Is Associated with Worse Outcomes in ST-Elevation
Myocardial Infarction Patients: Insights from the CARDINAL Trial
Sean van Diepen**, John P. Vavalle, L. Kristin Newby, Robert Clare, Karen S. Pieper,
Justin A. Ezekowitz, Judith S. Hochman, Kenneth W. Mahaffey, Paul W. Armstrong,
Christopher B. Granger
11:00–11:15 am
Hall A-10
Abstract Oral Session
More Frequent Self-Testing of Prothrombin Time Results in Improved Time in Target Range
David B. Matchar, Rowena Dolor, Alan Jacobson, Sean Love, Robert Edson, Lauren Uyeda
11:00–11:15 am
Hall A-1
Abstract Oral Session
Management and Outcomes of Patients with Moderate or Severe Functional Mitral Regurgitation and
Severe Left Ventricular Systolic Dysfunction
Zainab Samad, Hussein R. Al-Khalidi, Linda K. Shaw, Niels Risum, Andrew Wang, Eric J. Velazquez
11:15–11:30 am
Hall A-10
Abstract Oral Session
Apixaban versus Warfarin in Patients with Atrial Fibrillation in Relation to Prior Warfarin Use: Insights
from the ARISTOTLE Trial
David A. Garcia, John H. Alexander, Renato D. Lopes, Laine Thomas, Hongqiu Yang, Jack Ansell, Patrick
Commerford, Greg Flaker, Fernando Lanas, Puneet Mohan, Dragos Vinereanu, Denis Xavier, Christopher B.
Granger, Lars Wallentin
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
11:30–11:45 am
Room 503
Abstract Oral Session
Relations Between Baseline Physical Activity by Pedometer Counts and Future Cardiovascular Events in the
NAVIGATOR Study
William E. Kraus, Robert M. Califf, Jaakko Tuomilehto, Jie-Lena Sun, Laine Thomas, Thomas Yates, Melanie
Davies, Rury Holman, John J. McMurray, Angelyn Bethel, Steven M. Haffner
11:30–11:45 am
Hall A-4
Abstract Oral Session
Percutaneous Mechanical Assist: What Every Interventionalist Should Know
Counterpulsation: Is This Counterintuitive in 2012?
Manesh R. Patel
11:45 am –12:00 pm
Room 502b
Abstract Oral Session
In-Hospital Outcomes of Percutaneous Coronary Interventions in Extremely Obese and Normal Weight
Patients: Findings from NCDR®
Saeed Payvar, Sunghee Kim, Sunil V. Rao, Ronald Krone, Ramesh Daggubati
11:45 am –12:00 pm
Room 403a
Abstract Oral Session
Is Selection of Antiarrhythmic Drugs for Atrial Fibrillation Consistent with Guideline Recommendations:
Results from a Large Contemporary Community Cohort
Nancy M. Allen LaPointe, Yuliya Lokhnygina, Gillian Sanders, Eric D. Peterson, Sana M. Al-Khatib
12:00–12:45 pm
Science &
Technology Hall,
Booth 144
Meet the Trialists from LBCT.02
Quality of Life Outcomes in the Trial to Assess Chelation Therapy (TACT)
Daniel B. Mark
2:00–2:15 pm
Room 409
Abstract Oral Session
Heart Rate Reduction with Ivabradine Improves Regional Contractile Function and LV Dyssynchrony in a
Mouse Model of Reperfused Myocardial Infarction
Daniel M. O'Connor, Robert S. Smith, Bryan A. Piras, Dan Lin, John A. Hossack, Brent A. French
2:00–2:15 pm
Hall A-3
Abstract Oral Session
The Long-Term Need for Repeat Coronary Revascularization after Coronary Artery Bypass Surgery: The
Society of Thoracic Surgeons’ National Experience, 1990-2007
Emil L. Fosbol, Yue Zhao, David M. Shahian, Frederick L. Grover, Fred H. Edwards, Eric D. Peterson
2:00–5:10 pm
Hall A-8
Karen P. Alexander, Christopher B. Granger, moderators
2:00–5:10 pm
Hall A-10
Matthew T. Roe, moderator
2:00–5:10 pm
Hall A-7
Pierluigi Tricoci, moderator
2:15–2:30 pm
Hall A-8
Abstract Oral Session: Improving Care in AMI
Abstract Oral Session: Key Insights from Recent ACS Trials: Novel Therapeutics and Patient Outcomes
Abstract Oral Session: Antiplatelet Therapy in ACS: Monitoring, Switching, and Outcomes
Abstract Oral Session
Association of Hospital Myocardial Infarction Volume with Adherence to ACC/AHA Performance Measures:
Insights from the NCDR®
Robert W. Harrison**, Amy Miller, DaJuanicia Holmes, James de Lemos, Eric D. Peterson,
Tracy Y. Wang
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
2:30–2:45 pm
Room 404
Abstract Oral Session
Cardiopulmonary Resuscitation (CPR) Training Rates in the United States
Monique L. Anderson**, Margueritte Cox, Sana M. Al-Khatib, Kevin L. Thomas, Emil L. Fosbol,
Paul S. Chan, Graham Nichol, Eric D. Peterson
2:45–3:00 pm
Room 408b
Abstract Oral Session
Effects of Exercise Training on Outcomes in Women with Heart Failure: Analysis of the HF-ACTION Trial
by Gender
Ileana L. Pina, Vera Bittner, Robert Clare, Ann M. Swank, Andrew C. Kao, Robert E. Safford, Anil Nigam,
Denise Barnard, Mary M. Walsh, Stephen J. Ellis, Steven J. Keteyian
2:45–3:00 pm
Room 515b
Abstract Oral Session
Sildenafil Pharmacokinetics, Hemodynamic Efficacy and Safety after Stage II Single Ventricle Surgery
Kevin D. Hill, Robert Tunks, Gregory A. Fleming, John F. Rhodes, Matthew Laughon,
Michael Cohen-Wolkowiez, Jennifer S. Li
2:45–3:00 pm
Hall A-10
Abstract Oral Session
Vorapaxar, a Platelet Thrombin-Receptor Antagonist, in Medically Managed Patients with Non–ST-Segment
Elevation Acute Coronary Syndrome: Results from the TRACER Trial
Claes Held, Pierluigi Tricoci, Zhen Huang, Frans Van de Werf, Harvey White, Paul Armstrong,
Giuseppe Ambrosio, Philip Aylward, David Moliterno, Lars Wallentin, Edmond Chen, Aycan Erkan,
Lixin Jiang, John Strony, Robert Harrington, Kenneth W. Mahaffey
3:00–3:15 pm
Hall A-10
Abstract Oral Session
Net Clinical Benefit of Vorapaxar in NSTE ACS: Role of Ischemic and Bleeding Risk Stratification
Pierluigi Tricoci, Zhen Huang, Frans Van de Werf, Harvey White, David Moliterno, Basil Lewis, Claes Held,
Christoph Bode, Hisao Ogawa, Yuliya Lokhnygina, Philip Aylward, Lars Wallentin, Robert Harrington,
Kenneth W. Mahaffey, Paul Armstrong
3:00–3:15 pm
Room 501a
Abstract Oral Session
Race, Exercise Training, and Outcomes in Chronic Heart Failure
Robert J. Mentz, Vera Bittner, Aijing Z. Starr, Jerome L. Fleg, Gordon Moe, Ann M. Swank,
Meredith Fitz-Gerald, Anil Nigam, Andrew Kao, Anekwe Onwuanyi, William E. Kraus, David J. Whellan,
Stephen J. Ellis, Christopher M. O'Connor
3:00–3:15 pm
Room 503
Abstract Oral Session
Low Beta-Carotene Levels Are Associated with Elevated Insulin and Insulin Resistance in Healthy African
American Men and Women
Edward C. Suarez
3:00–3:15 pm
Room 518
Abstract Oral Session
Integration of Whole Genome Methylation with Metabolomics Identifies Novel Cardiovascular
Disease Genes
Svati H. Shah, Sheng Feng, Elizabeth Grass, Carol Haynes, Megan Chryst-Ladd, Damian Craig, Elizabeth R.
Hauser, Christopher B. Newgard, William E. Kraus, Simon G. Gregory
3:00–4:30 pm
Kentia Hall
Abstract Poster Session
Core 5, Poster 5129
EPC Mobilization after Erythropoietin Treatment in Acute ST-Elevation Myocardial Infarction: The REVEAL
EPC Substudy
Thomas J. Povsic, Sunil V. Rao, Samer S. Najjar, Laura G. Melton, Kristi Prather, Jiying Zhou,
Stacie D. Adams, Katherine L. Zavodni, Francine Kelly, Vic Hasselblad , John F. Heitner,
Subha V. Raman, Gregory W. Barsness, Manesh R. Patel, Raymond J. Kim, Edward G. Lakatta,
Robert A. Harrington
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
Core 2, Poster 2091
Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Subgroup Analysis
of the ROCKET AF Trial
Jonathan L. Halperin, Zachary Bloomgarden, Anne Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard
C. Becker, Günter Breithardt, Werner Hacke, Graeme Hankey, Christopher Nessel, Daniel Singer, Scott
Berkowitz, Robert M. Califf, Keith Fox, Kenneth W. Mahaffey
Core 3, Poster 3008
Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocyte: Insight into Mechanisms and Feasibility
in Human
Imke Kirste, Tilanthi M. Jayawardena, Maria Mirotsou, Victor J. Dzau
Core 6, Poster 6057
Genome Wide Association Study of Perioperative Myocardial Infarction Following Coronary Bypass Grafting
Mihai R. Podgoreanu, Miklos Kertai, Yi-Ju Li, John H. Alexander, Mark F. Newman, Peter K. Smith, Joseph P.
Mathew
Core 1, Poster 1014
A Novel Comprehensive RV Strain Analysis: Echocardiographic Approach to Define a Normal Adult
Population
Daniel E. Forsha, Niels Risum, Phillip B. Smith, Andrea Kropf, Sudarshan Rajagopal, Zainab Samad, Ronald J.
Kanter, Barker Piers, Joseph Kisslo
3:15–3:25 pm
Hall A-8
Abstract Oral Session: Improving Care in AMI
Karen P. Alexander, discussant
3:45–4:00 pm
Room 515b
Abstract Oral Session
Transplant-Free Survival, Catheter Interventions, and Events at 3 Years in the Single Ventricle
Reconstruction Trial
Jane W Newburger, Lynn A. Sleeper, Gail D. Pearson, William T Mahle, Carolyn Dunbar-Masterson,
Seema Mital, Ismee Williams, Andrew M. Atz, Nancy Ghanayem, Caren Goldberg, Jeff Jacobs,
Catherine D. Krawczeski, Alan Lewis, Sara K. Pasquali, Christian Pizarro, Peter J. Gruber, Svetlana Khaikin, J
William Gaynor, Richard Ohye
4:00–4:08 pm
Room 405
Controversies in ICD Management: Lead Advisories, MRI, DFTs
Predictors of High Defibrillation Energy Requirements: Results from the NCDR ICD Registry
Andrea M. Russo, Sana M. Al-Khatib, Yongfei Wang, Jeptha Curtis, Greg M. Marcus, Jonathan C. Hsu,
Nitesh Sood, Matthew W. Parker, Jeffrey Kluger, Rachel Lampert
4:00–4:15 pm
Hall A-3
Abstract Oral Session
Frequency and Prognostic Importance of Troponin and CK-MB Elevations Following Coronary Artery
Bypass Grafting: An Analysis from PRIMO I and PRIMO II
Robert W. Harrison**, Kyle White, Michael J. Domanski, Sorin J. Brener, Peter K. Smith,
Graham S. Hillis, Milo Engoren, John H. Alexander, Jerrold H. Levy, Bernard R, Chaitman,
Michael J. Mack, Michael E. Farkouh, Kenneth W. Mahaffey
4:00–4:15 pm
Hall A-8
Abstract Oral Session
The Impact of Smoking on Short- and Long-Term Outcomes in NSTEMI: Results from 38,628 Patients from
the CRUSADE Registry
Lan Shen**, Shuang Li, Laine Thomas, Tracy Y. Wang, Karen P. Alexander, Eric D. Peterson, Matthew T. Roe,
Bimal Shah
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
4:00–4:15 pm
Room 408a
Abstract Oral Session
Challenges in Managing Stage D Heart Failure: From VADs to Transplants
Michelle M. Kittleson, Garrick C. Stewart, Jennifer A. Cowger, Chetan B. Patel, Eduardo Rame,
Jeffrey Testani, Maria M. Mountis, Parag C. Patel, Frances L. Johnson, Maya E. Guglin, Jeffrey J. Teuteberg,
Jon A. Kobashigawa, Michele A. Hamilton
4:15–4:30 pm
Hall A-8
Abstract Oral Session
Relationship of Early Physician Follow-Up and 30-Day Readmission after Non–ST-Segment Elevation
Myocardial Infarction among Older Patients
Connie N. Hess**, S. Andrew Peng, Laine Thomas, Matthew T. Roe, Bimal R. Shah, Eric D. Peterson
4:30–4:45 pm
Room 408b
Abstract Oral Session
Trends and Outcomes in Mechanical Circulatory Support among Medicare Beneficiaries
Prateeti Khazanie**, Brad G. Hammill, Zubin J. Eapen, Lesley H. Curtis, Adrian F. Hernandez
4:30–4:45 pm
Hall A-7
Abstract Oral Session
Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Non–ST-Segment Elevation Acute
Coronary Syndrome Patients in TRACER
Kenneth W. Mahaffey, Zhen Huang, Pierluigi Tricoci, Frans Van de Werf, Harvey White,
Paul Armstrong, Claes Held, Sergio Leonardi, Philip Aylward, David Moliterno, Lars Wallentin,
Edmond Chen, John Strony, Robert Harrington
4:45–5:00 pm
Room 404
Abstract Oral Session
Distance, Treatment Strategy, and Mode of Transfer for Primary PCI in Patients Presenting to a Hospital
Without PCI Capability: A Report from the AHA Mission: Lifeline Program
Benjamin D. Nicholson, Harinder S. Dhindsa, Matthew T. Roe, Anita Y. Chen, James G. Jollis,
Michael C. Kontos
4:45–5:00 pm
Room 408b
Abstract Oral Session
Impact of Baseline Right Ventricular Dysfunction on the Effect of Adding Ventricular Reconstruction to
Surgical Revascularization in Patients with Ischemic Cardiomyopathy: Insights from the STICH Trial
Tomasz Kukulski, Lilin She, Normand Racine, Sinisa Gradinac, Andrey Marchenko, Julio Panza,
Eric J. Velazquez, Kwan L. Chan, Mark C. Petrie, Kerry L. Lee, Jae K. Oh
4:45–5:00 pm
Room 304ab
Abstract Oral Session
Coronary Artery Plaque Burden and Stenosis by Cardiovascular CT Correlate with Peripheral Gene
Expression in 614 Patients: Results from the PREDICT and COMPASS Studies
Szilard Voros, William Kraus, Matthew J. Budoff, Michael Elashoff, James Wingrove, Gregory Thomas,
Steven Rosenberg
5:00–5:10 pm
Hall A-8
Christopher B. Granger, discussant
5:00–5:10 pm
Hall A-10
Matthew T. Roe, discussant
5:00–5:10 pm
Hall A-7
Pierluigi Tricoci, discussant
5:30–5:45 pm
Room 503
Challenges and Opportunities with Appropriate Use Criteria: Strategies to Improve Care
Development Methodology for Appropriate Use Criteria
Abstract Oral Session: Improving Care in AMI
Abstract Oral Session: Key Insights from Recent ACS Trials: Novel Therapeutics and Patient Outcomes
Abstract Oral Session: Antiplatelet Therapy in ACS: Monitoring, Switching, and Outcomes
Manesh R. Patel
Duke at AHA 2012
Duke at AHA 2012
Monday, November 5
5:30–5:45 pm
Room 407
Atrial Fibrillation and Heart Failure: A Deadly Intersection
Importance of Atrial Fibrillation in Heart Failure
Lesley H. Curtis
5:45–6:00 pm
Room 408b
Acute Decompensated Heart Failure: Why Have We Failed?
Wrong End Points?
Adrian F. Hernandez
5:30–5:45 pm
Room 409
Joint AHA/Heart Failure Society of America Session: Controversies in CRT
CRT in Patients Without Left Bundle Branch Block
Jonathan P. Piccini
Tuesday, November 6
7:30–7:50 am
Room 406
How To Session
Aortic Stenosis
Andrew Wang
7:45–8:00 am
Room 409
The NHLBI Heart Failure Network: Developing the Future
Heart Failure Network 2.0: Tools for Success
Adrian F. Hernandez
8:00–8:15 am
Room 518
Ask the Experts
The Berlin Heart Experience
Robert Jaquiss
8:15–8:30 am
Hall A-8
Joint American Heart Association/Chinese Society of Cardiology Session: Global Registries—What Have
We Learned and What Are the Limitations?
Taking Registries to the Next Level: Randomization
Sunil V. Rao
8:20–8:45 am
Room 402
How To Session
Mission: Lifeline Cardiac Resuscitation Program
Christopher B. Granger
8:30–8:45 am
Hall A-8
Joint American Heart Association/Chinese Society of Cardiology Session: Global Registries—What Have
We Learned and What Are the Limitations?
How Registries Inform Guideline Recommendations
Eric D. Peterson
9:00–9:05 am
Petree Hall D
Selecting Options for the Patient with Advanced Heart Failure
How Registries Inform Guideline Recommendations
Yee Weng Wong**, case presentation
9:00–9:15 am
Room 505
Abstract Oral Session
Relation of Lipoprotein Levels to Cardiovascular Events in the Atherothrombosis Intervention in Metabolic
Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes (AIM-HIGH) Trial
John R. Guyton, April E. Slee, Todd Anderson, Jerome L. Fleg, Ronald B. Goldberg, Moti L. Kashyap,
Santica M. Marcovina, Stephen D. Nash, Kevin D. O'Brien, William Weintraub, Ping Xu, Xue-Qiao Zhao,
William E. Boden
Duke at AHA 2012
Duke at AHA 2012
Tuesday, November 6
9:00–9:15 am
Room 515b
Abstract Oral Session
Risk Factors for Prolonged Length of Stay Following Stage II Procedure in the Single Ventricle
Reconstruction Trial
Steven M. Schwartz, Minmin Lu, Richard G. Ohye, Kevin D. Hill, Andrew M. Atz, Maryam Naim,
Ismee Williams, Caren Goldberg, Alan Lewis, Frank Pigula, Peter Manning, Christian Pizarro, Paul Chai,
Phillip Burch, Carolyn Dunbar-Masterson, Jonathan Kaltman, Kirk Kanter, Lynn A. Sleeper, Julie Schonbeck,
Nancy Ghanayem for the Pediatric Heart Network Investigators
9:00–9:15 am
Hall A-10
Abstract Oral Session
Smad3 Loss Is Associated with Aortic Dilation and Spontaneous Aortic Rupture in Lean and in Obese
Diabetic db/db Mice
Anna Biernacka, Carlos Gonzalez-Quesada, Ping Kong, Vikrant Rai, Panagiota Christia, Marcin Dobaczewski,
Dong-Wook Lee, Xiao-Fan Wang, Nikolaos G. Frangogiannis
9:00–9:15 am
Room 407
Abstract Oral Session
Left Ventricular Systolic Dysfunction at Baseline and Follow-Up Is Associated with Long-Term Survival in
Chemotherapy Treated Breast Cancer Patients
Michel G. Khouri, Lee W. Jones, Linda K. Shaw, Pamela S. Douglas, Salvador Borges-Neto,
Eric J. Velazquez
9:00–9:15 am
Hall A-9
9:00 am –12:10 pm
Room 408b
Abstract Oral Session
Inducible Myocardial Ischemia and Outcomes in Patients with Coronary Artery Disease and Left Ventricular
Dysfunction Treated with Medical Therapy or Surgical Revascularization: A Report from the STICH Trial
Julio A. Panza, Thomas A. Holly, Federico M. Asch, Lilin She, Patricia A. Pellikka, Eric J. Velazquez,
Kerry L. Lee, Salvador Borges-Neto, Pedro S. Farsky, Robert H. Jones, Daniel S. Berman,
Robert O. Bonow
Abstract Oral Session: Treatments and Predictors of Hospitalized Heart Failure Patients
Adrian F. Hernandez, moderator
9:15–9:30 am
Room 408b
Abstract Oral Session
Does a Low Ejection Fraction Predict Mortality? Insights from the ASCEND-HF Trial
Mustafa Toma, Justin A. Ezekowitz, Christopher M. O’Connor, Adrian F. Hernandez, Jeffrey A. Bakal,
Muhammad Rizwan Sardar, Ronald Zolty, Barry M. Massie, Paul W Armstrong, Randall C. Starling
9:45–10:00 am
Hall A-4
Beat the Experts: Cath Lab Mysteries
ST Elevations: The Great Red Herring
Harry R. Phillips III
9:45–10:00 am
Room 406
Abstract Oral Session
Human Embryonic Stem Cell-Derived Cardiac Tissue Patch with Advanced Structure and Function
Donghui Zhang, Jason Lam, Brian Liau, Ralph Snodgrass, Nenad Bursac
9:45–10:00 am
Hall A-3
Abstract Oral Session
Epigenetic Modifications Are Associated with Ascending Thoracic Aneurysm Formation in Patients
with Bicuspid Aortic Valve
Asad A. Shah, Sheng Feng, Deidre Krupp, Carol Haynes, Elizabeth Grass, Shu S. Lin,
Elizabeth R. Hauser, William E. Kraus, Simon G. Gregory, Svati H. Shah, G. Chad Hughes
10:00–10:10 am
Room 408b
10:00–10:15 am
Room 501bc
Abstract Oral Session: Treatments and Predictors of Hospitalized Heart Failure Patients
Adrian F. Hernandez, discussant
Abstract Oral Session
Cost Effectiveness of Revascularization Strategies: A Preliminary Study from ASCERT
Zugui Zhang, Fred Edwards, Paul Kolm, Maria Grau-Sepulveda, Sean O’Brien, David Shahian,
Angelo Ponirakis, Lloyd W. Klein, Frederick L. Grover, Kirk Garratt, Charles Mckay, William S. Weintraub
Duke at AHA 2012
Duke at AHA 2012
Tuesday, November 6
11:00–11:15 am
Room 501bc
Abstract Oral Session
A Comparison of Temporal Trends in In-Hospital Adherence to Secondary Prevention Measures among
Patients Undergoing Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention, or No
Intervention: Insights from the GWTG-CAD
Dharam J. Kumbhani, Gregg C. Fonarow, Christopher P. Cannon, Adrian F. Hernandez, Eric D. Peterson, W. F.
Peacock, Warren K. Laskey, Maria Grau-Sepulveda, Lee H. Schwamm, Deepak L. Bhatt
11:00–11:15 am
Hall A-1
Abstract Oral Session
Annexin-A1 Tripeptide Attenuates Phosphorylation and Nuclear Translocation of NF-kB p65:
Cardioprotection in vitro and in vivo
Zhiquan Zhang, Qing Ma, G. Burkhard Mackensen, Mihai V. Podgoreanu
11:15–11:30 am
Room 501bc
Abstract Oral Session
Improvement in Adherence to Guideline-Based Therapy in Diabetic Patients Admitted with Acute Coronary
Syndrome: Findings from AHA Get With The Guidelines Program
Prakash Deedwania, Kamal Kotak, Gregg Fonarow, Christopher Cannon, Warren Laskey, Frank Peacock,
Wendy Pan, Deepak Bhatt
11:15–11:30 am
Hall A-1
Abstract Oral Session
The Cardioprotective Phenotype in Mammalian Hibernators Is Associated with Attenuation of
Reperfusion-Induced Nuclear Factor-Kappa B Regulated Myocardial Inflammation
Mihai V. Podgoreanu, Qing Ma, Zhiquan Zhang, James Bain, Christopher B. Newgard,
Matthias Riess, Brian M. Barnes
11:15–11:30 am
Hall A-4
Here Today, Home Today: Same-Day Percutaneous Coronary Intervention
In and Out: Setting Up a Same-Day PCI Program
Sunil V. Rao
11:30–11:45 am
Room 408b
Abstract Oral Session
Admission Heart Rate and In-Hospital Outcomes in Patients Hospitalized for Heart Failure
Anh L. Bui, Maria V. Grau-Sepulveda, Adrian F. Hernandez, Eric D. Peterson, Clyde W. Yancy,
Deepak L. Bhatt, Gregg C. Fonarow
11:30–11:45 am
Hall A-1
Abstract Oral Session
Adaptive Upregulation of MicroRNA-146b Following Surgical Ischemia-Reperfusion Attenuates
Myocardial Inflammation
Kevin A. Friede, Qing Ma, Kyle K. Phua, Zhiquan Zhang, Michael P. Smith, Kam W. Leong, Mircea Ivan,
Mihai V. Podgoreanu
11:30–11:45 am
Hall A-4
Abstract Oral Session
Here Today, Home Today: Same-Day Percutaneous Coronary Intervention
Prevalence and Outcomes with Same-Day Percutaneous Coronary Intervention
Eric D. Peterson
11:45 am –12:00 pm
Room 408b
2:00–3:25 pm
Hall A-2
Abstract Oral Session
Variation in Quality of Care among Patients Hospitalized with Acute Heart Failure in an International Trial:
Findings from ASCEND-HF
Jonathan G. Howlett, Justin A. Ezekowitz, Mohua Podder, Adrian F. Hernandez, Rafael Diaz,
Kenneth Dickstein, Paul W. Armstrong, Gregg C. Fonarow
Abstract Oral Session: Pharmacology for ACS and PCI
E. Magnus Ohman, moderator
Duke at AHA 2012
Duke at AHA 2012
Tuesday, November 6
2:10–2:30 pm
Hall A-2
Abstract Oral Session
Impact of the Use of Different Bleeding Scales on the Rate of 6-Month Bleeding after PCI: Results
from the PARIS Registry
Georgios Vlachojannis, Giora Weisz, Bernhard Witzenbichler, Timothy D. Henry, Annapoorna S. Kini,
Thomas Stuckey, David J. Cohen, Peter B. Berger, Antonio Colombo, Ioannis Iakovou, Philippe Gabriel Steg,
David J. Moliterno, David Atoniucci, Ron Waksman, Mitchell W. Krucoff, Raj Vadde, Elliot Elias, Jennifer Yu,
Leila Khalili, Samantha Sartori, Usman Baber, Roxana Mehran
2:45–3:00 pm
Room 409
Abstract Oral Session
Who Is Being Referred for TAVR?: Patterns of Referral for TAVR at a Single Academic Medical Center
James A. Nelson Jr., John Vavalle, Sharif Halim**, G. Chad Hughes, Andrew Wang, Lynne Koweek, Donald
Glower, Jeff Gaca, John Alexander, John K. Harrison
3:00–3:15 pm
Hall A-8
Abstract Oral Session
Novel MicroRNA 874 Is a Unique Angiogenic Modulator of Stem Cell Paracrine Factor Epidermacan
Ying Zhang, Yangfan Liu, Pete Pow-anpongkul, Vinogran Naidoo, J. Alan Payne, Hui Mu,
Nicholas Katsanis, Maria Mirotsou, Victor J. Dzau
3:00–4:30 pm
Kentia Hall
Abstract Poster Session
Core 2, Poster 2068
Reduction in Bleeding with Apixaban versus Warfarin Is Consistent Across Subgroups and Locations: Insights
from the ARISTOTLE Trial
Elaine M. Hylek, Claes Held, John H. Alexander, Renato D. Lopes, Raffaele DeCaterina, Kurt Huber,
Petr Jansky, Gabriel Steg, Michael Hanna, Lars Wallentin, Christopher B. Granger
Core 2, Poster 2073
Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, a Tablet with
Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies
David J. Whellan, Jay L. Goldstein, James M. Scheiman, Alan B. Miller, John G. Fort, Ying Zhang,
Christopher M. O'Connor
Core 3, Poster 3018
Characteristics of Pediatric Cardiovascular Clinical Trials Registered on ClinicalTrials.gov
Kevin D. Hill, Karen Chiswell, Wendy K.K. Lam, Jennifer S. Li
Core 6, Poster 6011
Does Type of Culprit Lesion Matter in Patients with Acute Coronary Syndrome and Prior Coronary Artery
Bypass Graft Surgery Undergoing Percutaneous Coronary Intervention?
Ralf E. Harskamp**, Marcel A. Beijk, Peter E. Damman, Jan G. Tijssen, Mitchell W. Krucoff,
Renato D. Lopes, Robbert J. de Winter
Core 5, Poster 5083
Metabolomic and Gene Expression Changes in End-Stage Heart Failure Are Reversed by Left Ventricular
Assist Device
Anisha Gupte, Dale J. Hamilton, Andrea M. Cordero-Reyes, Keith A. Youker, Matthias Loebe,
Robert D. Stevens, Brett Wenner, Olga Ilkayeva, Heinrich Taegtmeyer, Christopher B. Newgard,
Guillermo Torre-Amione, Willa A. Hsueh
Core 2, Poster 2031
Depression Inhibits the Positive Effects of Exercise and Light-to-Moderate Alcohol Consumption on
C-Reactive Protein Levels
Edward C. Suarez
3:45–3:53 pm
Room 403b
Innovations in Preventing AF-Related Thromboembolism
Racial Differences in Atrial Fibrillation Prevalence and Anticoagulation Use
Kevin L. Thomas, Jonathan P. Piccini, Li Liang, Paul Heidenreich, Gregg Fonarow, Eric D. Peterson,
Clyde Yancy, Adrian F. Hernandez
Duke at AHA 2012
Duke at AHA 2012
Tuesday, November 6
3:45–4:00 pm
Hall A-1
Abstract Oral Session
Sex Paradox: Greater Hemodilution Yet Lower Rate of Acute Kidney Injury in Women Compared with Men
Undergoing On-Pump Cardiac Surgery
Rajendra H. Mehta, Andrea Ballotta, Alessandro Frigiola, Eduardo Bossone, Marco Ranucci
3:45–4:00 pm
Hall A-3
Abstract Oral Session
Outcomes in Extended-Criteria Caradiac Transplantation: A 10-Year Experience
Ashleigh A. Owen, Marc Samsky, Chetan Patel, Adrian F. Hernandez, Jacob Jentzer,
Phillip Schulte, G. Michael Felker, Paul B. Rosenberg, Carmelo A. Milano, Joseph G. Rogers
3:45–3:55 pm
Petree Hall D
Late-Breaking Clinical Trials: Management of LV Dysfunction: Devices and Drugs
MADIT Randomized Trial to Reduce Inappropriate Therapy (MADIT-RIT)
Arthur J. Moss, presenter; Claudio Schuger, Christoper Beck, M. Brown, David Cannom, James Daubert,
Mark Estes, Henry Greenberg, W. Jackson Hall, David Huang, Joseph Kautzner, Helmut Klein, Scott McNitt,
Brian Olshansky, Morio Shoda, David Wilber, Wojciech Zareba
4:15–4:30 pm
Room 308
Abstract Oral Session
Mechanical Dyssynchrony Defined by Phase Analysis from GSPECT: Does it Predict Mortality?
Paul L. Hess**, Linda K. Shaw, Mary L. Shepherd, Michael MacKenzie, Robert Pagnanelli, Mona Fiuzat, Jonathan
P. Piccini, Sana M. Al-Khatib, Christopher M. O'Connor, Salvador Borges-Neto
4:45–5:00 pm
Room 515a
Abstract Oral Session
Genetic Variants in the Bone Morphogenic Protein (BMP) Family of Genes Interact with Mobile Source
Air Pollution to Increase Risk of Peripheral Arterial Disease
Cavin Ward-Caviness, Lucas Neas, Carol Haynes, Colette Blach, Elizabeth Burns,
Karen LaRocque-Abramson, Elaine Dowdy, Wayne Casco, Robert Devlin, David Diaz-Sanchez,
William E. Kraus, Svati H. Shah, Simon G. Gregory, Marie L. Miranda, Elizabeth R. Hauser
4:45–5:00 pm
Room 408a
Abstract Oral Session
Inhibition of Wnt6 by Sfrp2 Regulates CPC Differentiation by Differential Modulation of Canonical and
Non-Canonical Wnt Pathways
Amanda K. Verma, Jeffrey Schmeckpeper, Lucy Yin, Lunan Zhang, Farideh Beigi, Alan Payne, Zhiping Zhang,
Richard Pratt, Victor J. Dzau, Maria Mirotsou
4:45–5:00 pm
Room 518
Abstract Oral Session
Surgeon Volume Is Associated with Operative Mortality after Congenital Cardiac Surgery
Karl F. Welke, Tara Karamlou, Xia He, Marshall L. Jacobs, Jeffery P. Jacobs, Sara K. Pasquali
4:51–5:01 pm
Petree Hall D
Late-Breaking Clinical Trials: Management of LV Dysfunction: Devices and Drugs
The RELAXin in Acute Heart Failure (RELAX-AHF) Trial
John R. Teerlink, presenter; Gad Cotter, Beth A. Davison, G. Michael Felker, Gerasimos Filippatos,
Barry H. Greenberg, Piotr Ponikowski, Elaine Unemori, Adriaan A. Voors, Angelo Trapani, C. Bush,
Christoph Schumacher, Thomas Severin, Marco Metra
5:13–5:23 pm
Petree Hall D
Late-Breaking Clinical Trials: Management of LV Dysfunction: Devices and Drugs
Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart
Failure Clinical Research Network
Bradley A Bart, presenter; Steven R. Goldsmith, Kerry L. Lee, Lynne W. Stevenson, Christopher M. O'Connor,
David A. Bull, Margaret M. Redfield, Anita Deswal, Jean L. Rouleau, Martin M. LeWinter,
E.O. Ofili, Michael M. Givertz, Marc J. Semigran, G. Michael Felker, Hao H. Chen, Adrian F. Hernandez, Kevin J.
Anstrom, Steven E. McNulty, Eric J. Velazquez, Alice M. Mascette, Eugene Braunwald
Duke at AHA 2012
Duke at AHA 2012
Tuesday, November 6
5:30–5:42 pm
Hall A-7
Recent Highlights from Circulation Research
MicroRNA-Mediated in vitro and in vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
Victor J. Dzau
5:30–5:42 pm
Hall A-3
The Next Breakthrough in Caring for the Patient with Cardiovascular Disease and Stroke: Systems of Care
(Mission: Lifeline, Get With The Guidelines)
Why Quality and Systems Matter
Eric D. Peterson
5:30–5:45 pm
Room 408b
Key for Heart Failure Success: Prevention
Importance of Prevention
Douglas D. Schocken
5:30–5:45 pm
Hall A-4
Advancing Transradial Interventions
Transradial Angiography and Intervention: Best Practices for Best Outcomes
Sunil V. Rao
5:42–5:54 pm
Hall A-3
The Next Breakthrough in Caring for the Patient with Cardiovascular Disease and Stroke: Systems of Care
(Mission: Lifeline, Get With The Guidelines)
Mission: Lifeline
Christopher B. Granger
5:45–6:00 pm
Room 407
Hospital to Home: Transitions in Care
Bringing e-Tools to Improving Quality of Care
Zubin J. Eapen
6:00–6:15 pm
Room 503
Surrogate Outcomes: Important Insights or Expensive Distractions?
Should We Abandon Surrogate End Points and Focus on Precision of Difference in Clinically Important
Benefits?
Kevin J. Anstrom
6:15–6:30 pm
Room 503
Surrogate Outcomes: Important Insights or Expensive Distractions?
Large Simple Trials Evaluating Meaningful Outcomes Are the Solution
Robert M. Califf
6:15–6:30 pm
Room 410
Biomarkers in Heart Failure: Pathophysiology, Prognosis, and Monitoring
Monitoring Disease and Guiding Therapy
G. Michael Felker
Wednesday, November 7
7:30–7:45 am
Hall A-10
How to Make and Control iPS Cells
MicroRNA-Mediated Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
Maria Mirotsou
7:30–8:45 am
Hall A-11
Sunil V. Rao, moderator
Ask the Experts
7:30–8:45 am
Room 407
Mitchell W. Krucoff, moderator
8:00–8:15 am
Hall A-11
Ask the Experts
Why Are the Risk Factors for Recurrent Events the Same as the Risk Factors for Bleeding?
Cardiac Disease and Safety with Cancer Treatment: A Compelling Need for Cooperation
Kenneth W. Mahaffey
Duke at AHA 2012
Duke at AHA 2012
Wednesday, November 7
8:15–8:30 am
Room 408b
Management of Myocardial Ischemia in Heart Failure
Intervention and Surgery
Eric J. Velazquez
8:15–8:30 am
Room 407
Cardiac Disease and Safety with Cancer Treatment: A Compelling Need for Cooperation
Standardization of Reporting of Cardiac Events Is Critical to Understanding Cardiac Safety Issues
Chiara Melloni
9:00–9:15 am
Hall A-3
Abstract Oral Session
Extent of Coronary Artery Disease and Outcomes after Ticagrelor Administration: Insights from The
PLATelet Inhibition and Patient Outcomes (PLATO) Trial
Emmanouil S. Brilakis, Claes Held, Bernhard Meier, Frank Cools, Marc J. Claeys, Jan H. Cornel,
Philip Aylward, Basil S. Lewis, Douglas W. Weaver, Gunnar Brandrup-Wognsen, Susanna Stevens,
Lars Wallentin, Stefan K. James
9:05–9:17 am
Petree Hall D
The Heart Team in Action: From Evidence to Everyday Decision Making in Ischemic Heart Disease
Guidelines and Evidence for Multivessel Revascularization
Peter K. Smith
9:15–9:30 am
Hall A-3
Abstract Oral Session
Outcomes with Ticagrelor versus Clopidogrel in Relation to High Sensitivity Troponin-T in Non–ST-Elevation
Acute Coronary Syndrome Patients Managed with Early Invasive or Non-Invasive Treatment: A Substudy
from the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial
Lars Wallentin, Stefan K. James, Evangelos Giannitsis, Hugo A Katus, Richard C. Becker,
Christopher P. Cannon, Jay Horrow, Steen Husted, Agneta Siegbahn, Gabriel Ph Steg, Robert F Storey,
Lisa Wernroth, Robert A. Harrington, for the PLATO Study Group
9:15–9:30 am
Hall A-4
Adjunctive Pharmaceuticals for Coronary and Peripheral Interventions
Antithrombotic Agents: Are We There Yet?
Richard C. Becker
9:30–9:45 am
Hall A-3
Abstract Oral Session
Vorapaxar, a Platelet Thrombin-Receptor Antagonist, in Patients with Non–ST-Segment Elevation Acute
Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from the TRACER Trial
Marco Valgimigli, Pierluigi Tricoci, Zhen Huang, Philip Aylward, Paul Armstrong, Harvey White,
Petr Widimsky, Robert Harrington, Angel Cequier, Khaled Ziada, Ming-Fong Chen, Edmond Chen,
Yuliya Lokhnygina, Lars Wallentin, John Strony, Kenneth W. Mahaffey, David Moliterno
9:30–9:45 am
Hall A-4
Adjunctive Pharmaceuticals for Coronary and Peripheral Interventions
Resistance to Antiplatelet Agents and Outcomes: Genomics and Predictability
Deepak Voora
9:30–9:45 am
Hall A-2
Abstract Oral Session
Do Interventional Cardiology Training Programs Have Worse Outcomes Early in the Academic Year? An
Assessment of the “July Effect” from the NCDR®
Beau Hawkins, Lisa Kaltenbach, Daniel Shivapour, Megan Neely, Sunil V. Rao, Robert Yeh
Duke at AHA 2012
Duke at AHA 2012
Wednesday, November 7
9:30–11:00 am
Kentia Hall
Abstract Poster Session
Core 7, Poster 7070
A Phase 3, Randomized, Partially Blinded, Active-Controlled, Study Assessing the Efficacy and Safety of
Intramyocardial Autologous CD34+ Cell Administration in Patients with Refractory Angina: Design of the
RENEW Study
Thomas J. Povsic, Douglas W. Losordo, Kenneth Story, Candice E. Junge, Richard A. Schatz,
Robert A. Harrington, Charles J. Davidson, David F. Fortuin, Dean J. Kereiakes, Farrell O. Mendelsohn,
Warren Sherman, Timothy D. Henry
Core 7, Poster 7127
The Influence of Presenting Electrocardiographic Findings on the Treatment and Outcomes of Patients with
Non-ST-Elevation Myocardial Infarction (NSTEMI)
Jigar H. Patel, Raghav Gupta, Matthew T. Roe, S. Andrew Peng, Jorge F. Saucedo
Core 7, Poster 7128
The Forgotten Lead: Does aVR ST-Deviation Add Insight into STEMI Patients?
Aws Alherbish, Cynthia M. Westerhout, Yuling Fu, Christopher B. Granger, Paul W. Armstrong
Core 2, Poster 2016
Radiofrequency Ablation of Supraventricular Arrhythmias Reduces Physician Visits and Improves Social
Functional Status
Mauro Lencioni, Kathleen Withers, Hannah Patrick, Kathryn Wood, Stephen Murray, Michael Griffith
Core 6, Poster 6017
Patient Selection for Bare Metal Stent Placement and Associated Longitudinal Outcomes Before and After
the FDA Drug-Eluting Stent Advisory
Robert W. Harrison**, David Dai, Matthew T. Roe, John C. Messenger, H. Vernon Anderson,
Eric D. Peterson, Tracy Y. Wang
Core 6, Poster 6006
Impact of the SYNTAX Score on Revascularization Outcomes for Patients with Multi-Vessel Disease
C. Michael Gibson, Meagan Doherty, Cassandra Abueg, Lakshmi Gopalakrishnan, Varun Kumar,
Sean O'Brian, Maria Grau-Sepulveda, Fred Edwards, Lloyd Klein, William Weintraub
Core 4, Poster 4030
Registry to Evaluate Anticoagulation with Warfarin in Atrial Fibrillation (REAL-AF)
David Garcia, Gregory P. Samsa, Zhaohui Su, Michael D. Ezekowitz, David B. Matchar
Core 7, Poster 7109
Plasma Proteomics Reveal Greater Upregulation of Thrombomodulin in Patients Treated with Rivaroxaban
Compared with Warfarin
Mark Chan, Min Lin, Derek Cyr, Joseph Lucas, Will Thompson, Arthur Moseley, Hitoshi Ueda,
Mariko Kajikawa, Richard C. Becker
Core 1, Poster 1025
Health and Economic Outcomes after Detection of Incidental Pulmonary Nodules During Cardiac CT
Angiography in Patients with Suspected Coronary Artery Disease
Alexander Goehler, Pamela McMahon, Heidi S. Lumish, Carol Wu, Vidit Munish, Michael Gilmore,
Jonathan H. Chung, Emily L. Siegel, Daniel B. Mark, Quynh Troung, G. Scott Gazelle, Udo Hoffmann
Core 5, Poster 5037
Variation in Intravenous Inotrope Use for Patients Hospitalized with Heart Failure: Data from Get With
The Guidelines
Larry A. Allen, Gregg C. Fonarow, Maria V. Grau-Sepulveda, Adrian F. Hernandez, Pamela N. Peterson,
Chohreh Partovian, Paul A. Heidenrich, Deepak L. Bhatt, Eric D. Peterson, Harlan M. Krumholz
Duke at AHA 2012
Duke at AHA 2012
Wednesday, November 7
Core 3, Poster 3011
Metabolites Reporting on Mitochondrial Function Predict Response to Biventricular Pacing
Svati H. Shah, Happy Thakkar, Asad A. Shah, Nicholas D. Andersen, James Bain, Carol Haynes, Michael
Muehlbauer, Robert Stevens, Kent Nilsson, Jonathan P. Piccini, Jason Koontz, Albert Sun, Christopher B.
Newgard, Patrick M. Hranitzky
Core 3, Poster 3030
Cancer Risk Estimation from Cardiac Catheterization in Children with Heart Disease
Jason N. Johnson, Christoph P. Hornik, Jennifer S. Li, Sara K. Pasquali, Terry Yoshizumi,
Robert E. Reiman, Donald P. Frush, Kevin D. Hill
Core 5, Poster 5050
Association Between Resting Heart Rate, Chronotropic Index, and Long-term Outcomes in Patients with
Heart Failure Receiving Beta-Blocker Therapy: Data from the HF-ACTION Trial
Daniela Dobre, Faiez Zannad, Steven J. Keteyian, Susanna R. Stevens, Patrick Rossignol, Delane K. Kitzman,
Joel Landzberg, Jonathan Howlett, William E. Kraus, Stephen J. Ellis
9:45–10:00 am
Hall A-2
Abstract Oral Session
State Mandated Public Reporting of Percutaneous Coronary Intervention Outcomes Is Associated with
Better Outcomes: A Report from the NCDR®
Matthew A. Cavender, Karen E. Joynt, Frederick S. Resnic, Craig S. Parzynski, John S. Rumsfeld, Mauro
Moscucci, Frederick A. Masoudi, Jeptha P. Curtis, Eric D. Peterson, Hitinder S. Gurm
9:45–10:00 am
Room 502b
Abstract Oral Session
Plasma Levels of Galectin-3 in the Community: Galectin-3 is Associated with Pre-Clinical Ventricular
Dysfunction and Subsequent Incident Heart Failure and Mortality
Omar F. AbouEzzeddine, Garvan C. Kane, Richard J. Rodeheffer, Horng H. Chen, Amy K. Saenger,
Jose N. Nativi, Christopher G. Scott, G. Michael Felker, Allan S. Jaffe, John C. Burnett Jr.,
Margaret M. Redfield
9:45–10:00 am
Room 409
Abstract Oral Session
Elevated Galectin-3 Levels and Prediction of Mode of Death in Heart Failure: Insights from the
HF-ACTION Study
Tariq Ahmad**, Mona Fiuzat, Susanna R. Stevens, Kirkwood F. Adams, David J. Whellan,
Mark P. Donahue, Dalane W. Kitzman, Ileana L. Piña, Faiez Zannad, William E. Kraus,
Christopher M. O'Connor, G. Michael Felker
10:00–10:15 am
Hall A-2
Abstract Oral Session
Patterns of Red Blood Cell Transfusion Use in Patients Undergoing Percutaneous Coronary Intervention in
Contemporary Clinical Practice
Matthew W. Sherwood**, Yongfei Wang, Jeptha P. Curtis, Eric D. Peterson, Sunil V. Rao
11:15–11:30 am
Room 303
Abstract Oral Session
A Novel, Comprehensive RV Strain Analysis: Frequently Encountered Ventricular Activation Abnormalities in
the Systemic Right Ventricle
Daniel E. Forsha, Niels Risum, Phillip B. Smith, Zainab Samad, Ronald J. Kanter, Piers Barker, Joseph Kisslo
11:15–11:30 am
Room 502b
Abstract Oral Session
Plasma Levels of ST2 in the Community: ST2 Is Associated with Increased Risk of Incident Heart Failure and
Mortality but not with Altered Ventricular Function
Omar F. AbouEzzeddine, Garvan C. Kane, Richard J. Rodeheffer, Horng H. Chen, Amy K. Saenger,
Christopher G. Scott, G. Michael Felker, Allan S. Jaffe, John C. Burnett Jr., Margaret M. Redfield
Duke at AHA 2012
Duke at AHA 2012
Wednesday, November 7
11:15–11:30 am
Room 403b
Abstract Oral Session
Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and
Warfarin in the ROCKET AF Trial
Jonathan P. Piccini, Susanna R. Stevens, Yuliya Lokhnygina, Manesh R. Patel, Daniel Singer, Jonathan Halperin,
Graeme Hankey, Werner Hacke, Richard C. Becker, Christopher Nessel,
Kenneth W. Mahaffey, Keith Fox, Robert M. Califf, Günter Breithardt
11:30–11:45 am
Room 409
Abstract Oral Session
Changes in Troponin I and Outcomes in Acute Heart Failure: Data from the Pre-RELAX study
G. Michael Felker, Marco Metra, Piotr Ponikowski, Adriaan A. Voors, Barry Greenberg,
Germasimos Filippatos, Elaine Unemori, Gad Cotter, Beth Davidson, Thomas Severin, Christopher Bush,
Guenther Mueller-Velten, Rajnish Saini, John R. Teerlink
11:45 AM–12:00 pm
Room 405
Abstract Oral Session
Connexin-43 Gene Variants are Associated with Risk of Ventricular Arrhythmias in Patients with a Depressed
Ejection Fraction
Happy Thakkar, Jonathan P. Piccini, Albert Y. Sun, Carol Haynes, Elizabeth Grass, Kent Nilsson, Jason I. Koontz,
Patrick Hranitzky, Svati H. Shah
11:45 AM–12:00 pm
Room 408b
Abstract Oral Session
Do Patients with Heart Failure and Atrial Fibrillation Adhere to Warfarin after Hospital Discharge? Findings
from the Get With The Guidelines–Heart Failure Registry and Medicare Linked Database
Zubin J. Eapen, Xiaojuan Mi, Gregg C. Fonarow, Paul A. Heidenreich, Lesley H. Curtis,
Adrian F. Hernandez, Sana M. Al-Khatib
11:45 AM–12:00 pm
Hall A-5
Abstract Oral Session
Frequency of Non-Systems Delays in STEMI Patients Undergoing Primary PCI and Implications for Door-toBalloon Time Reporting. A Report from the AHA Mission: Lifeline Program
David A. Cotoni, Matthew T. Roe, Shuang Li, George W. Vetrovec, Michael C. Kontos
2:00–2:15 pm
Room 515b
Abstract Oral Session
Factors Associated with Impaired Neurodevelopment at 3 Years of Age in Children with Single Right
Ventricle Lesions
Caren S. Goldberg, Minmin Lu, William T. Mahle, J. W. Gaynor, Ismee Williams, Kathleen A. Mussatto,
Richard G. Ohye, Deborah Frank, Eric M. Graham, Jeffrey P. Jacobs, Catherine D. Krawczeski, Linda Lambert,
Alan Lewis, Victoria L. Pemberton, Renee Sananes, Erica Sood, Stephanie Wechsler, Jane W. Newburger, for
the Pediatric Heart Network Investigators
2:00–5:10 pm
Room 408b
Abstract Oral Session: Predicting Response to Cardiac Resynchronization Therapy: The Role of
Echocardiography
Kevin Jackson, moderator
4:00–4:15 pm
Hall A-3
Abstract Oral Session
Adoption of Radial Access and Comparison of Outcomes to Femoral Approach in Percutaneous Coronary
Intervention: An Updated Report from the NCDR® (2007-2011)
Dmitriy N. Feldman, Rajesh V. Swaminathan, Lisa Kaltenbach, Dmitri Baklanov, Luke K Kim, S. Chiu Wong,
Robert M. Minutello, John Messenger, Issam Moussa, Kirk Garratt, Robert N. Piana, William B Hillegass,
Mauricio Cohen, Ian C. Gilchrist, Sunil V. Rao
Duke at AHA 2012
Duke at AHA 2012